Previous 10 |
Shares of Alpha Tau Medical (NASDAQ: DRTS) were skyrocketing 23.9% as of 3:26 p.m. ET on Thursday. Trading of the stock was even halted temporarily as part of the market "circuit-breaker" triggers. The company didn't announce any news, however. Today's move appears to be a conti...
Gainers: JX Luxventure Limited (LLL) +43%. Alpha Tau Medical (DRTS) +37%. Takung Art (TKAT) +31%. Emclaire Financial (EMCF) +32%. BiondVax (BVXV) +30%. Mercurity Fintech Holding (MFH) +26%. INmune Bio (INMB) +19%. Gracell (GRCL) +21%. Aptevo (APVO) +21%. Lilium (LILM) +20%. LiqTech Internatio...
Gainers: BiondVax Pharmaceuticals (BVXV) +39%. Alpha Tau Medical (DRTS) +38%. CollPlant Biotechnologies (CLGN) +10%. Aptevo Therapeutics (APVO) +8%. HOOKIPA Pharma (HOOK) +8%. Losers: Sonendo (SONX) -11%. Creative Medical Technology (CELZ) -9%. Lan...
Shares of Alpha Tau Medical Ltd. (NASDAQ: DRTS) stock climbed 42% on Wednesday. The Israeli medical-device company is focusing on the commercialization of its Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) to treat solid tumors. The stock closed at $10.32 a share on Tue...
Gainers: Creative Medical Technology Holdings CELZ +74%. 4D pharma LBPS +26%. XORTX Therapeutics (XRTX) +26%. Clear Secure YOU +24%. Alpha Tau Medical (DRTS) +21%. Waterdrop WDH +21%. Cenntro Electric Group CENN +20%. Femasys FEMY +20%. Q&K International Grou...
News, Short Squeeze, Breakout and More Instantly...
Alpha Tau Medical Ltd. Company Name:
DRTS Stock Symbol:
NASDAQ Market:
Alpha Tau Medical Ltd. Website:
The pooled analysis included data from 4 i nternational clinical trials spanning a n array of hard-to-treat indications including skin, head & neck, and oral cavity. Initial response data demonstrated an overall response rate of almost 100% in tre...
2024-05-21 10:00:22 ET Jason Bednar from Piper Sandler issued a price target of $7.00 for DRTS on 2024-05-21 08:51:00. The adjusted price target was set to $7.00. At the time of the announcement, DRTS was trading at $2.91. The overall price target consensus is at $12.00 ...
JERUSALEM, May 21, 2024 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, today announced that CFO Raphi Levy will present a corporate overview an...